Famicord Group stores over 600,000 samples & has supplied stem cells for treatment of around 3450 patients in more than 35 countries. We supply for the biggest, specialized in stem cells therapies clinics and we also provide products in GMP standard for clinical trails. What You should know, is that our stem cells helped patients with various indications, such as: neurological (cerebral palsy, ALS, autism and more) ophthalmic orthopedic oncological (i.e. GvHD – Graft-versus-host disease) dermatological (i.e. chronic wounds) For more details, please see below.
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health. FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
Cord blood stem cells have been used in treatments for over 30 years and can help to treat 80 diseases today. In transplants cord blood stem cells help to rebuild a healthy blood and immune system that has been damaged by disease. Over the last few years, cord blood use has expanded beyond transplant medicine into areas of regenerative medicine in clinical research trials for conditions once thought untreatable, like autism and brain injuries. The tissue of the umbilical cord is an additional source of valuable stem cells called Mesenchymal Stem Cells. Mesenchymal Stem Cells (MSCs) can rapidly divide, regenerate, and differentiate into many cell types including neural cells, bone cells, and cartilage. They also have the ability to respond to inflammation and aid in tissue repair. Cord tissue banking allows families to secure an additional source of stem cells that work in a different way than cord blood stem cells do.
The tissue of the umbilical cord is an additional source of valuable stem cells called Mesenchymal Stem Cells. MSCs can rapidly divide, regenerate, and differentiate into many cell types including neural cells, bone cells, and cartilage. They also have the ability to respond to inflammation and aid in tissue repair. Cord tissue banking allows families to secure an additional source of stem cells that work in a different way than cord blood stem cells do.
The umbilical cord tissue may be processed and stored in different ways, which are not equa.1
FamiCord Group goes an extra mile not only to freeze and storage a cord tissue stem cells, but also to prepare the advance therapy medicinal product when needed. Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.
FamiCord Group own 2 laboratories which fullfil the GMP standards requilred by European Medicines Agency.
Over 1700 patients have benefited from cord tissue stem cells prepared by our laboratories. Full number of patitents, who are cured by stem cells is avaliable here https://famicord.eu/about-us/list-of-life-saving-transplantations.
1 M. Sivell, Not all umbilical cord tissue banks are the same: Does storage method compromise parent access? To learn more about cord blood banking, https://parentsguidecordblood.org/pl/node/242
Have a Question? Let's Connect!
Arch. Makariou III 256, Eftapato Building, Office 3, 3rd Floor – 3105 – Limassol Cyprus
Tel: +35725710133
Copyright © 2023 Famicord Group. All rights reserved.
